Fusion Muscles: How Do They Occur And What Are They?

how does fusion muscles occur

Myoblast fusion is a critical process for skeletal muscle development and regeneration. It occurs when two types of muscle cells, muscle founder cells and fusion-competent myoblasts, recognise and adhere to each other. This process involves the exchange of cytoplasmic material and the merging of cell membranes. The role of specific proteins in myoblast fusion has been the subject of recent research, with the discovery of muscle-specific fusion proteins, Myomaker and Myomerger-Minion, offering new insights into the biology of this process.

Characteristics Values
Myoblast fusion Occurs between muscle founder cells and fusion competent myoblasts (FCMs)
Muscle founder cells Act as "seeds" that attract FCMs
FCMs Take on the identity and features of the original founder cell
Fusion Requires recognition and adhesion between founder cells and FCMs
Fusion Requires both fusing cells to express myomaker and only one to express myomerger

cyvigor

Myoblast fusion is critical for skeletal muscle development and regeneration

For myoblast fusion to occur, two fusion partners must recognise each other, adhere their plasma membranes, open fusion pores to allow cytoplasmic material exchange, and ultimately merge into one cell. Recognition and adhesion between founder cells and FCMs are mediated by immunoglobulin (Ig) domain-containing CAMs (type I transmembrane protein). Experiments performed with cultured C2C12 myoblasts have demonstrated a bilateral requirement for myomaker and a unilateral requirement for myomerger, meaning that both fusing cells must express myomaker, but only one needs to express myomerger. This is consistent with a model in which myomaker induction of hemifusion involves membrane modifications on both cells, whereas the role of myomerger in pore formation is mediated from one side alone.

The fusion of muscle precursor cells is a required event for proper skeletal muscle development and regeneration. Numerous proteins have been implicated in myoblast fusion, but the majority are expressed in diverse tissues and regulate numerous cellular processes. The discovery of two muscle-specific fusion proteins, Myomaker and Myomerger-Minion, has allowed for significant advances in our knowledge of myoblast fusion.

cyvigor

Myoblast fusion occurs between muscle founder cells and fusion competent myoblasts

Myoblast fusion is critical for skeletal muscle development and regeneration. It occurs between muscle founder cells and fusion-competent myoblasts (FCMs). Founder cells act as "seeds" that attract FCMs and determine the position, orientation, size, epidermal attachment and nerve innervation pattern of the future multinucleated muscle fibres.

For myoblast fusion to occur, two fusion partners must recognise each other, adhere their plasma membranes, open up fusion pores to allow cytoplasmic material exchange and, ultimately, merge into one cell. The rate-limiting step for successful myoblast fusion is bringing two cell membranes into close proximity to facilitate fusion pore formation. Recognition and adhesion between founder cells and FCMs are mediated by immunoglobulin (Ig) domain-containing CAMs (type I transmembrane protein).

Experiments performed with cultured C2C12 myoblasts have repeatedly demonstrated a bilateral requirement for myomaker and a unilateral requirement for myomerger. This means that both fusing cells must express myomaker, but only one needs to express myomerger. This is consistent with a model in which myomaker induction of hemifusion involves membrane modifications on both cells, whereas the role of myomerger in pore formation must be mediated from one side alone.

Within a native tissue context, myoblast fusion can take place in one of two scenarios: (i) fusion of multiple progenitors to form multinucleated myofibers de novo, or (ii) fusion of myoblasts to existing myofibers, occurring notably during postnatal growth and adult muscle hypertrophy or regeneration. The smallest muscles of the embryo will be formed by fusion of as few as 3-5 cells, whereas larger muscles require approximately 30-35 cells.

cyvigor

Myoblast fusion requires the expression of myomaker and myomerger

Myoblast fusion is critical for skeletal muscle development and regeneration. It occurs between two types of muscle cells: muscle founder cells and fusion-competent myoblasts (FCMs). Muscle founder cells act as "seeds" that attract FCMs, ultimately determining the position, orientation, size, epidermal attachment and nerve innervation pattern of the future multinucleated muscle fibres.

For myoblast fusion to occur, two fusion partners must recognise each other, adhere their plasma membranes, open up fusion pores to allow cytoplasmic material exchange and, ultimately, merge into one cell. This process is mediated by immunoglobulin (Ig) domain-containing CAMs (type I transmembrane protein).

Experiments have demonstrated a bilateral requirement for myomaker and a unilateral requirement for myomerger. This means that both fusing cells must express myomaker, but only one needs to express myomerger. Myomaker and myomerger are two muscle-specific fusion proteins that have been discovered. The role of myomaker involves membrane modifications on both cells, while the role of myomerger in pore formation is mediated from one side alone.

cyvigor

Myoblast fusion is initiated by founder cells

Myoblast fusion is critical for skeletal muscle development and regeneration. It occurs between two types of muscle cells: muscle founder cells and fusion-competent myoblasts (FCMs). Founder cells act as "seeds" that attract FCMs, determining the position, orientation, size, epidermal attachment and nerve innervation pattern of the future multinucleated muscle fibres.

For myoblast fusion to occur, two fusion partners must recognise each other, adhere their plasma membranes, open up fusion pores to allow cytoplasmic material exchange and, ultimately, merge into one cell. The rate-limiting step for successful myoblast fusion is bringing two cell membranes into close proximity to facilitate fusion pore formation. Recognition and adhesion between founder cells and FCMs are mediated by immunoglobulin (Ig) domain-containing CAMs (type I transmembrane protein).

Experiments performed with cultured C2C12 myoblasts have demonstrated a bilateral requirement for myomaker and a unilateral requirement for myomerger. Both fusing cells must express myomaker, but only one needs to express myomerger. This is consistent with a model in which myomaker induction of hemifusion involves membrane modifications on both cells, whereas the role of myomerger in pore formation is mediated from one side alone.

Founder cells initiate fusion with surrounding "naive" FCMs, which then take on the identity and features of the original founder cell. The final size of the muscle fibre is attained through multiple rounds of fusion of the developing syncitia with additional FCMs. The smallest muscles of the embryo will be formed by fusion of as few as three to five cells, whereas larger muscles require approximately 30-35 cells.

cyvigor

Myoblast fusion is a required event for proper skeletal muscle development

Myoblast fusion is a critical event for skeletal muscle development. It occurs when two types of muscle cells, muscle founder cells and fusion-competent myoblasts (FCMs), recognise and adhere to each other. The muscle founder cells act as "seeds" that attract the FCMs, determining the position, orientation, size, epidermal attachment and nerve innervation pattern of the future multinucleated muscle fibres.

For myoblast fusion to occur, the two fusion partners must recognise each other and adhere their plasma membranes. Fusion pores then open up to allow for the exchange of cytoplasmic material, and the two cells ultimately merge into one. The rate-limiting step for successful myoblast fusion is bringing two cell membranes into close proximity to facilitate fusion pore formation.

Myoblast fusion can take place in one of two ways: the fusion of multiple progenitors to form multinucleated myofibers de novo, or the fusion of myoblasts to existing myofibers, which occurs during postnatal growth and adult muscle hypertrophy or regeneration. In the first scenario, founder cells initiate fusion with surrounding "naive" FCMs, which then take on the identity and features of the original founder cell. The final size of the muscle fibre is attained through multiple rounds of fusion of the developing syncitia with additional FCMs. The smallest muscles of the embryo will be formed by the fusion of as few as 3-5 cells, whereas larger muscles require approximately 30-35 cells.

Numerous proteins have been implicated in myoblast fusion, including Myomaker and Myomerger–Minion, two muscle-specific fusion proteins. Experiments performed with cultured C2C12 myoblasts have demonstrated a bilateral requirement for myomaker and a unilateral requirement for myomerger. This means that both fusing cells must express myomaker, but only one needs to express myomerger.

Frequently asked questions

Myoblast fusion is the fusion of muscle precursor cells, which is required for skeletal muscle development and regeneration.

Myoblast fusion occurs between two types of muscle cells: muscle founder cells and fusion-competent myoblasts (FCMs). The founder cells act as "seeds" that attract the FCMs and determine the position, orientation, size, epidermal attachment and nerve innervation pattern of the future multinucleated muscle fibres.

For myoblast fusion to occur, two fusion partners must recognise each other, adhere their plasma membranes, open up fusion pores to allow cytoplasmic material exchange and, ultimately, merge into one cell.

Myomaker and Myomerger are two muscle-specific fusion proteins that have been discovered to be involved in myoblast fusion.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment